FAQs

MedShare CI is not another data aggregator—it is a clinical intelligence layer built specifically for decision-makers like insurance brokers, stop-loss carriers, and self-funded employers.

Instead of delivering raw records or fragmented data, MedShare uses FHIR-based APIs and AI to assemble purpose-built, permissioned clinical summaries tailored for underwriting, renewal analysis, and care management.

Result: Faster decisions, less manual chart chasing, and more accurate risk visibility.

MedShare CI operates under a secure, permissioned data model that aligns with HIPAA requirements:

• Data is accessed via FHIR APIs from leading EHR systems (Epic, Cerner, Athena, etc.)
• Access is governed through Business Associate Agreements (BAAs) and member consent (opt-in or enrollment-based authorization)
• Only the minimum necessary data is retrieved for the specific use case

Result: Enterprise-grade compliance with full auditability—without exposing unnecessary PHI.

MedShare CI gives brokers something they’ve never had before—direct clinical insight at the point of decision-making.

With MedShare CI, brokers can:

• Identify high-cost claim risks before renewal
• Validate conditions behind large claims
• Support stop-loss negotiations with real clinical data
• Provide employers with data-backed cost reduction strategies

Result: Brokers become strategic advisors—not just intermediaries—while improving retention and revenue.

MedShare CI is designed for speed and scalability:

• Real-time or near real-time data retrieval via API connections
• Rapid assembly of clinical summaries across multiple providers and systems
• No need for manual record requests or fax-based workflows

Result: Insights that used to take weeks can now be delivered in hours or days—when they actually matter.

MedShare CI is purpose-built for high-impact, high-cost decision points across the healthcare ecosystem:

• Stop-loss underwriting: Identify risks like oncology, dialysis, transplants, NICU
• Renewals: Validate claims and uncover cost drivers
• PBM & specialty pharmacy: Ensure diagnosis-to-drug alignment
• Population health: Target high-risk members for early intervention
• Self-funded employers: Reduce catastrophic claims and improve outcomes

Result: Immediate ROI through better decisions, reduced risk, and lower healthcare spend.